Baseline characteristics of FLDMD, SLDMD and placebo arms.

<p>Baseline characteristics of FLDMD, SLDMD and placebo arms.</p

Flow chart of systematic review.

<p>*One study could be included at 12 and 24 months. DMD: Disease Modifying Drug; FLDMD: First-line DMD; SLDMD: Second-line DMD; PCB: Placebo; BPF: Brain Parenchymal Fraction; SIENA: Structural Image Evaluation, using Normalisation, of Atrophy.</p

Primary characteristics of the 35 included studies.

<p>Primary characteristics of the 35 included studies.</p

sj-docx-1-msj-10.1177_13524585231218149 – Supplemental material for COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022

Supplemental material, sj-docx-1-msj-10.1177_13524585231218149 for COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022 by Lina Jeantin, Edouard Januel, Pierre Labauge, Elisabeth Maillart, Jérôme de Seze, Hélène Zéphir, Jean Pelletier, Philippe Kerschen, Damien Biotti, Olivier Heinzlef, Laurent Guilloton, Caroline Bensa, Marie Théaudin, Sandra Vukusic, Olivier Casez, Aude Maurousset, David Laplaud, Eric Berger, Christine Lebrun-Frenay, Bertrand Bourre, Pierre Branger, Bruno Stankoff, Pierre Clavelou, Eric Thouvenot, Eric Manchon, Thibault Moreau, François Sellal, Mickaël Zedet, Caroline Papeix and Céline Louapre in Multiple Sclerosis Journal</p

sj-docx-4-msj-10.1177_13524585231223880 – Supplemental material for Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society

Supplemental material, sj-docx-4-msj-10.1177_13524585231223880 for Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society by Nicolas Collongues, Françoise Durand-Dubief, Christine Lebrun-Frenay, Bertrand Audoin, Xavier Ayrignac, Caroline Bensa, Kévin Bigaut, Bertrand Bourre, Clarisse Carra-Dallière, Jonathan Ciron, Gilles Defer, Arnaud Kwiatkowski, Emmanuelle Leray, Elisabeth Maillart, Romain Marignier, Guillaume Mathey, Nathalie Morel, Eric Thouvenot, Hélène Zèphir, Julie Boucher, Clémence Boutière, Pierre Branger, Angélique Da Silva, Sarah Demortière, Maxime Guillaume, Benjamin Hebant, Edouard Januel, Anne Kerbrat, Eric Manchon, Xavier Moisset, Alexis Montcuquet, Chloé Pierret, Julie Pique, Julien Poupart, Chloé Prunis, Thomas Roux, Perrine Schmitt, Géraldine Androdias and Mikael Cohen in Multiple Sclerosis Journal</p

sj-docx-2-msj-10.1177_13524585231223880 – Supplemental material for Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society

Supplemental material, sj-docx-2-msj-10.1177_13524585231223880 for Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society by Nicolas Collongues, Françoise Durand-Dubief, Christine Lebrun-Frenay, Bertrand Audoin, Xavier Ayrignac, Caroline Bensa, Kévin Bigaut, Bertrand Bourre, Clarisse Carra-Dallière, Jonathan Ciron, Gilles Defer, Arnaud Kwiatkowski, Emmanuelle Leray, Elisabeth Maillart, Romain Marignier, Guillaume Mathey, Nathalie Morel, Eric Thouvenot, Hélène Zèphir, Julie Boucher, Clémence Boutière, Pierre Branger, Angélique Da Silva, Sarah Demortière, Maxime Guillaume, Benjamin Hebant, Edouard Januel, Anne Kerbrat, Eric Manchon, Xavier Moisset, Alexis Montcuquet, Chloé Pierret, Julie Pique, Julien Poupart, Chloé Prunis, Thomas Roux, Perrine Schmitt, Géraldine Androdias and Mikael Cohen in Multiple Sclerosis Journal</p

sj-docx-3-msj-10.1177_13524585231223880 – Supplemental material for Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society

Supplemental material, sj-docx-3-msj-10.1177_13524585231223880 for Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society by Nicolas Collongues, Françoise Durand-Dubief, Christine Lebrun-Frenay, Bertrand Audoin, Xavier Ayrignac, Caroline Bensa, Kévin Bigaut, Bertrand Bourre, Clarisse Carra-Dallière, Jonathan Ciron, Gilles Defer, Arnaud Kwiatkowski, Emmanuelle Leray, Elisabeth Maillart, Romain Marignier, Guillaume Mathey, Nathalie Morel, Eric Thouvenot, Hélène Zèphir, Julie Boucher, Clémence Boutière, Pierre Branger, Angélique Da Silva, Sarah Demortière, Maxime Guillaume, Benjamin Hebant, Edouard Januel, Anne Kerbrat, Eric Manchon, Xavier Moisset, Alexis Montcuquet, Chloé Pierret, Julie Pique, Julien Poupart, Chloé Prunis, Thomas Roux, Perrine Schmitt, Géraldine Androdias and Mikael Cohen in Multiple Sclerosis Journal</p

sj-docx-1-msj-10.1177_13524585231223880 – Supplemental material for Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society

Supplemental material, sj-docx-1-msj-10.1177_13524585231223880 for Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society by Nicolas Collongues, Françoise Durand-Dubief, Christine Lebrun-Frenay, Bertrand Audoin, Xavier Ayrignac, Caroline Bensa, Kévin Bigaut, Bertrand Bourre, Clarisse Carra-Dallière, Jonathan Ciron, Gilles Defer, Arnaud Kwiatkowski, Emmanuelle Leray, Elisabeth Maillart, Romain Marignier, Guillaume Mathey, Nathalie Morel, Eric Thouvenot, Hélène Zèphir, Julie Boucher, Clémence Boutière, Pierre Branger, Angélique Da Silva, Sarah Demortière, Maxime Guillaume, Benjamin Hebant, Edouard Januel, Anne Kerbrat, Eric Manchon, Xavier Moisset, Alexis Montcuquet, Chloé Pierret, Julie Pique, Julien Poupart, Chloé Prunis, Thomas Roux, Perrine Schmitt, Géraldine Androdias and Mikael Cohen in Multiple Sclerosis Journal</p